Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 3:10 PM ET 5/22/2013
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
14,799 | 13,607 | 2,755 | 63,209 | 3,677 |
Depreciation & Amortization Expense |
537 | 505 | 496 | 449 | 486 |
SG&A Expense |
37,493 | 37,092 | 33,640 | 31,240 | 32,608 |
Research & Development |
11,252 | 11,416 | 12,963 | 16,107 | 24,702 |
Other SG&A |
26,241 | 25,676 | 20,677 | 15,133 | 7,906 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
NA | 0 | 0 | NA | 0 |
Non Operating Income/Expense |
-5 | -3 | -4 | -22 | 9 |
Equity in Affiliates (Pretax) |
NA | 0 | NA | 0 | 0 |
Interest Expense |
126 | 668 | 591 | 57 | 33 |
Gross Interest Expense |
126 | 668 | 591 | 57 | 33 |
Pretax Income |
-68,298 | -24,638 | -31,956 | 31,454 | -29,441 |
Income Tax |
-27 | 0 | 0 | 1 | 0 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
-68,271 | -24,638 | -31,956 | 31,453 | -29,441 |
Minority Interest Expense |
0 | 0 | 0 | 0 | 0 |
Net Income |
-68,271 | -24,638 | -31,956 | 31,453 | -29,441 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
-68,271 | -24,638 | -31,956 | 31,453 | -29,441 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
-68,271 | -24,638 | -31,956 | 31,453 | -29,441 |
Operational EPS |
-1.91 | -0.68 | -0.89 | 0.87 | -0.88 |
EPS (basic) |
-0.82 | -0.68 | -0.89 | 0.88 | -0.88 |
EBITDA |
-22,694 | -23,485 | -30,885 | 47,102 | -28,931 |
Depreciation & Amortization Expense |
537 | 505 | 496 | 449 | 486 |
Common Shares Outstanding |
35,704 | 36,350 | 36,075 | 36,338 | 33,288 |
Basic Shares Outstanding |
35,704 | 36,350 | 36,075 | 35,772 | 33,288 |
Diluted Shares Outstanding |
35,704 | 36,350 | 36,075 | 36,338 | 33,288 |
Diluted EPS after Extraordinary Items |
-1.91 | -0.68 | -0.89 | 0.87 | -0.88 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
-1.91 | -0.68 | -0.89 | 0.88 | -0.88 |
*Figures in thousands of U.S. Dollars except shares outstanding.